Prestige Consumer Healthcare (PBH) EBT Margin (2010 - 2025)
Prestige Consumer Healthcare's (PBH) quarterly EBT Margin came in at 21.81% in Q4 2025, down 580.0% year-on-year from 4.54% in Q4 2024, and down 13.53% quarter-over-quarter from 25.22% in Q3 2025.
Prestige Consumer Healthcare (PBH) EBT Margin (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's EBT Margin history runs 16 years deep, the most recent figure standing at 21.81% for Q4 2025.
- On a quarterly basis, EBT Margin fell 580.0% year-over-year to 21.81% in Q4 2025; TTM through Dec 2025 was 24.16%, a 66.0% decrease from a year earlier, with the FY2025 full-year figure at 24.98%, up 45.0% from the prior year.
- EBT Margin slipped to 21.81% in Q4 2025 per PBH's latest filing, from 25.22% in the prior quarter.
- Across five years, EBT Margin topped out at 28.37% in Q2 2021 and bottomed at 104.78% in Q1 2023.
- The 5-year median for EBT Margin is 24.6% (2023), against an average of 17.59%.
- Across the five-year window, EBT Margin slumped 12761 bps in 2023 and soared 12908 bps in 2024, its largest moves.
- Year by year, EBT Margin stood at 23.86% in 2021, then increased by 4 bps to 24.72% in 2022, then fell by 0 bps to 24.61% in 2023, then climbed by 12 bps to 27.61% in 2024, then fell by 21 bps to 21.81% in 2025.
- Per Business Quant, the three latest PBH EBT Margin figures stand at 21.81% (Q4 2025), 25.22% (Q3 2025), and 24.76% (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 10.97% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 33.51% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -41.57% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 40.73% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -7.05% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 30.30% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.35% |
| 10 | Prestige Consumer Healthcare | 2.34 Bn | 2.28 Bn | 157.37 Mn | 21.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 21.81% |
| Sep 30, 2025 | 25.22% |
| Jun 30, 2025 | 24.76% |
| Mar 31, 2025 | 24.94% |
| Dec 31, 2024 | 27.61% |
| Sep 30, 2024 | 25.25% |
| Jun 30, 2024 | 21.87% |
| Mar 31, 2024 | 24.30% |
| Dec 31, 2023 | 24.61% |
| Sep 30, 2023 | 24.59% |
| Jun 30, 2023 | 24.60% |
| Mar 31, 2023 | -104.78% |
| Dec 31, 2022 | 24.72% |
| Sep 30, 2022 | 23.02% |
| Jun 30, 2022 | 25.59% |
| Mar 31, 2022 | 22.84% |
| Dec 31, 2021 | 23.86% |
| Sep 30, 2021 | 21.59% |
| Jun 30, 2021 | 28.37% |
| Mar 31, 2021 | 16.98% |